HFS
BMY icon

Hantz Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Hantz Financial Services’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$710K Sell
12,325
-683
-5% -$39.2K 0.01% 609
2026
Q1 		$789K Buy
13,008
+3,185
+32% +$186K 0.01% 532
2025
Q4 		$530K Buy
9,823
+1,643
+20% +$79K 0.01% 592
2025
Q3 		$369K Buy
8,180
+2,921
+56% +$136K 0.01% 608
2025
Q2 		$243K Buy
5,259
+769
+17% +$37.7K ﹤0.01% 592
2025
Q1 		$274K Buy
4,490
+70
+2% +$4.08K ﹤0.01% 543
2024
Q4 		$250K Buy
4,420
+71
+2% +$3.97K ﹤0.01% 546
2024
Q3 		$225K Sell
4,349
-106
-2% -$4.97K ﹤0.01% 556
2024
Q2 		$185K Buy
4,455
+1,671
+60% +$74.8K ﹤0.01% 569
2024
Q1 		$151K Sell
2,784
-154
-5% -$7.84K ﹤0.01% 584
2023
Q4 		$151K Sell
2,938
-202
-6% -$10.6K ﹤0.01% 576
2023
Q3 		$182K Sell
3,140
-95,774
-97% -$5.87M ﹤0.01% 553
2023
Q2 		$6.33M Buy
98,914
+663
+0.7% +$44.5K 0.16% 176
2023
Q1 		$6.81M Buy
98,251
+1,332
+1% +$93.9K 0.19% 160
2022
Q4 		$6.97M Buy
96,919
+3,279
+4% +$247K 0.21% 148
2022
Q3 		$6.66M Buy
93,640
+2,014
+2% +$146K 0.23% 139
2022
Q2 		$7.05M Buy
91,626
+3,656
+4% +$278K 0.24% 131
2022
Q1 		$6.42M Buy
87,970
+5,086
+6% +$341K 0.19% 158
2021
Q4 		$5.17M Buy
82,884
+3,558
+4% +$209K 0.15% 177
2021
Q3 		$4.69M Buy
79,326
+39,829
+101% +$2.62M 0.15% 176
2021
Q2 		$2.64M Buy
39,497
+3,477
+10% +$227K 0.1% 217
2021
Q1 		$2.27M Buy
36,020
+277
+0.8% +$17.2K 0.09% 224
2020
Q4 		$2.22M Buy
35,743
+176
+0.5% +$10.8K 0.1% 215
2020
Q3 		$2.14M Buy
+35,567
New +$2.14M 0.11% 199

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hantz Financial Services's BMY Position: Q2 2026 in Review

Hantz Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 5.3% in Q2 2026, selling an estimated $39.2K and leaving 12,325 shares worth $710K. The position accounts for 0.01% of the portfolio, ranked #609.

Hantz Financial Services first reported a position in BMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $7.05M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hantz Financial Services held 12,325 shares of Bristol-Myers Squibb worth $710K as of Q2 2026.
  • Hantz Financial Services sold 683 Bristol-Myers Squibb shares in Q2 2026, an estimated $39.2K.
  • Bristol-Myers Squibb made up 0.01% of Hantz Financial Services's portfolio in Q2 2026, its #609 holding.
  • Hantz Financial Services first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 24 quarters since.
  • Hantz Financial Services's Bristol-Myers Squibb position peaked at $7.05M in Q2 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.